Archive Newsletter
-
05.29.25 -- Efficiently And Safely Manufacture Cell & Gene Therapies
5/29/2025
05/29/25 Cell & Gene Newsletter
-
05.29.25 -- Enhance Safety In Cell And Gene Therapies
5/29/2025
05/29/25 Cell & Gene Newsletter
-
05.29.25 -- Key Considerations For Early-Stage CGT Companies When Selecting A CDMO
5/29/2025
05/29/25 Cell & Gene Newsletter
-
05.28.25 -- Protecting Intellectual Property In The Genomics Revolution
5/28/2025
05/28/25 Cell & Gene Newsletter
-
05.27.25 -- Enhancing Safety And Speed In CGT Manufacturing: Assays, Plasmids, And More
5/27/2025
05/27/25 Cell & Gene Newsletter
-
05.27.25 -- STREAM Edition: Freezing Studies For Single-Use Solutions: Long-Term (Part 2)
5/27/2025
05/27/25 Cell & Gene Newsletter
-
05.27.25 -- Ferring Builds A Global Gene Therapy Manufacturing Network Around ADSTILADRIN
5/27/2025
05/27/25 Cell & Gene Newsletter
-
05.23.25 -- Accelerate Your Cell And Gene Therapy Research
5/23/2025
05/23/25 Cell & Gene Newsletter
-
05.23.25 -- Distributed Cell Therapy Manufacturing Trade-Offs You Should Know About
5/23/2025
05/23/25 Cell & Gene Newsletter
-
05.22.25 -- Hard Lessons In Parenteral Automatic Visual Inspection
5/22/2025
05/22/25 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more